Blonder Tongue Laboratories, Inc. (BDRL) Stock Analysis
DELISTED 2026
What happened to Blonder Tongue Laboratories, Inc. (BDRL) stock?
Blonder Tongue Laboratories, Inc. (BDRL) no longer trades on public markets. It was delisted in January 2026. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Blonder Tongue Laboratories, Inc. (BDRL) trades at $0.00873. Blonder Tongue Laboratories, Inc. specializes in television signal encoding, transcoding, digital transport, and broadband product solutions. Sector: Technology.
Last analyzed: Mar 16, 2026Analyst Coverage for BDRL: BDRL does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BDRL against Technology peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
BDRL: 2/2 scored disciplines lean bearish. Dominant signal: Izzy Englander bullish.
How is this calculated? →Blonder Tongue Laboratories, Inc. (BDRL) Technology Profile & Competitive Position
Blonder Tongue Laboratories, Inc. provides television signal processing and distribution solutions, including encoding, transcoding, and digital transport equipment, primarily in the United States. With a focus on both commercial and SMB applications, the company offers a suite of products ranging from headend equipment to customer premise equipment (CPE) and related services.
What Is the Investment Thesis for BDRL?
Blonder Tongue Laboratories, Inc. presents a challenging investment case given its small market capitalization and negative profitability. The company's gross margin of 32.0% indicates some pricing power, but its negative profit margin of -14.0% raises concerns about operational efficiency. A potential growth catalyst lies in the increasing demand for advanced video encoding and transcoding solutions, driven by the growth of streaming services and IPTV. However, the company's ability to capitalize on these opportunities is contingent on its ability to improve profitability and manage its cost structure effectively. Investors should closely monitor the company's financial performance and its ability to innovate in a rapidly evolving technology landscape. The company's beta of 0.84 suggests lower volatility compared to the overall market.
Based on FMP financials and quantitative analysis
BDRL Key Highlights
Blonder Tongue Laboratories, Inc. operates in the technology sector, specifically within the communication equipment industry.
- The company's gross margin stands at 32.0%, indicating a moderate ability to control production costs.
- Blonder Tongue has a negative profit margin of -14.0%, highlighting challenges in achieving profitability.
- The company's beta is 0.84, suggesting it is slightly less volatile than the market.
- Blonder Tongue Laboratories, Inc. has 67 employees.
Who Are BDRL's Competitors?
BDRL is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| DLTI DLT Resolution Inc. | $0.60 | +9.09% | $48.4M | 50 |
| TTLTF Total Telcom Inc. | $0.35 | -1.69% | $9.28M | 53 |
| ATGN Altigen Communications, Inc. | $0.50 | +1.91% | $13.0M | 52 |
| BYLTF Baylin Technologies Inc. | $0.18 | +0.22% | $27.4M | 53 |
| ELSLF Elsight Limited | $0.32 | +0.00% | $48.1M | 60 |
| WSTL Westell Technologies, Inc. | $6.02 | +0.17% | $61.3M | 56 |
| ENAFF Enablence Technologies Inc. | $3.01 | -24.75% | $63.4M | 65 |
| MOB Mobilicom Ltd. | $5.95 | -5.48% | $71.1M | 59 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are BDRL's Key Strengths?
Long-standing history in the industry.
- Comprehensive product portfolio.
- Technical expertise in signal processing.
- Service offerings provide recurring revenue.
What Are BDRL's Weaknesses?
Small market capitalization.
- Negative profit margin.
- Limited financial resources.
- Dependence on the US market.
What Could Drive BDRL Stock Higher?
Increased demand for IPTV and streaming services driving demand for encoding and transcoding solutions.
- Expansion of broadband infrastructure and increasing internet penetration creating opportunities for coax distribution products.
- Potential partnerships with technology companies to expand product offerings and reach new markets.
- Development and launch of new and innovative products to address evolving customer needs.
What Are the Key Risks for BDRL?
Financial-distress signal — its Altman Z-Score of -4.42 sits in the distress zone (elevated bankruptcy risk).
- Rapid technological advancements could render existing products obsolete.
- Intense competition from larger and more established companies.
- Economic downturns could reduce demand for the company's products and services.
- Limited financial resources may hinder the company's ability to invest in research and development.
- Dependence on the US market exposes the company to regional economic risks.
What Are the Growth Opportunities for BDRL?
- Expansion in the IPTV Market: The increasing adoption of IPTV services presents a significant growth opportunity for Blonder Tongue. As more consumers switch to internet-based television, the demand for IPTV format conversions and simulcast solutions will rise. Blonder Tongue's NXG IP digital video processing and headend products are well-positioned to capitalize on this trend. The global IPTV market is projected to reach $115.74 billion by 2028, growing at a CAGR of 8.2% from 2021. Blonder Tongue can leverage its expertise to capture a larger share of this expanding market.
- Development of Advanced Encoding/Transcoding Solutions: The demand for high-quality video encoding and transcoding solutions is growing, driven by the increasing popularity of 4K and ultra-high definition content. Blonder Tongue's encoders/transcoders, which support various formats such as MPEG-2, MPEG-4/H.264, and HEVC/H.265, are well-suited to meet this demand. By investing in the development of even more advanced encoding technologies, such as AI-powered video compression, Blonder Tongue can gain a competitive edge and attract new customers. The video encoding and transcoding market is expected to reach $3.9 billion by 2027.
- Penetration of the SMB Market: Blonder Tongue's coax distribution products, including amplifiers, taps, and splitters, are well-suited for use in SMB environments. By targeting this market segment, Blonder Tongue can diversify its customer base and reduce its reliance on larger cable television systems. The SMB market is characterized by a large number of potential customers and a growing demand for reliable video distribution solutions. Blonder Tongue can leverage its existing product portfolio and expertise to capture a significant share of this market.
- Expansion of Service Offerings: Blonder Tongue can expand its service offerings to include more value-added services, such as installation, maintenance, and support. By providing comprehensive service packages, Blonder Tongue can increase customer loyalty and generate recurring revenue streams. The market for video distribution services is growing, driven by the increasing complexity of video delivery infrastructure. Blonder Tongue can leverage its technical expertise to provide high-quality services that meet the needs of its customers.
- Strategic Partnerships: Forming strategic partnerships with other technology companies can help Blonder Tongue expand its product offerings and reach new markets. For example, Blonder Tongue could partner with a company that specializes in cloud-based video management solutions to offer a complete end-to-end solution for video distribution. By leveraging the strengths of its partners, Blonder Tongue can accelerate its growth and enhance its competitive position. These partnerships could focus on integrating Blonder Tongue's hardware with complementary software solutions.
What Are BDRL's Competitive Advantages?
- Established history in the television and broadband technology space (founded in 1950).
- Comprehensive product portfolio covering encoding, transcoding, distribution, and CPE.
- Technical expertise in television signal processing and digital transport.
- Service level agreements and services provide recurring revenue.
What Does BDRL Do?
Founded in 1950 and headquartered in Old Bridge, New Jersey, Blonder Tongue Laboratories, Inc. has a long history in the television and broadband technology space. The company develops and manufactures a range of products focused on television signal encoding, transcoding, digital transport, and broadband distribution. Its offerings include encoders/transcoders that support various formats such as 4K/ultra-high definition, MPEG-2, MPEG-4/H.264, and HEVC/H.265. These products cater to the evolving needs of content providers and distributors looking to optimize their video delivery infrastructure. Blonder Tongue also provides NXG IP digital video processing and headend products, which are essential for IPTV format conversions and simulcast applications. Their coax distribution products, including amplifiers, taps, and splitters, are used in cable television systems and SMB environments to ensure reliable signal distribution. Additionally, the company offers CPE products like Android-based IPTV set-top boxes, digital modulation products such as Aircastertm ATSC, QAM, and IP trans-modulators, and DOCSIS data products. These products enable customers to create and manage their own content lineups for coax IP distribution. Beyond hardware, Blonder Tongue provides service level agreements and services, along with analog modulation, fiber, and miscellaneous products and services. They also offer test and measurement instruments and contract manufacturing services, further diversifying their revenue streams. With 67 employees, Blonder Tongue continues to serve the US market with its comprehensive suite of television and broadband solutions.
What Products and Services Does BDRL Offer?
- Provides television (TV) signal encoding solutions.
- Offers transcoding services for various video formats.
- Delivers digital transport solutions for video content.
- Manufactures broadband product solutions.
- Provides coax distribution products like amplifiers and splitters.
- Offers CPE products consisting of Android-based IPTV set top boxes.
- Develops digital modulation products.
How Does BDRL Make Money?
- Sells encoders and transcoders for various video formats.
- Provides coax distribution products for signal distribution.
- Offers CPE products like Android-based IPTV set top boxes.
- Generates revenue through service level agreements and services.
What Industry Does BDRL Operate In?
Blonder Tongue Laboratories, Inc. operates within the communication equipment industry, which is characterized by rapid technological advancements and evolving consumer preferences. The market is driven by the increasing demand for high-quality video streaming and IPTV services. Competition is intense, with companies like AAPJ, BTVRF, CRTG, DGMA, and DLTI vying for market share. Blonder Tongue's focus on encoding, transcoding, and digital transport solutions positions it to capitalize on the growing need for efficient video delivery infrastructure. However, the company must navigate the challenges of technological disruption and competitive pressures to maintain its market position.
Who Are BDRL's Key Customers?
- Cable television systems
- Small and medium-sized businesses (SMBs)
- Content providers
- IPTV service providers
Company Profile
Blonder Tongue Laboratories, Inc. operates in the Communication Equipment industry within the Technology sector. It is headquartered in Old Bridge, US. The company is led by CEO Robert J. Palle Jr.. BDRL has traded publicly since 1995.
BDRL Revenue & Earnings Trend
In Q1 2025, BDRL generated $2.9M in top-line revenue, marking a sequential increase of 0.2%. The company recorded a net loss of $314K, with diluted EPS of $-0.02. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this unknown Technology company. Across the four most recent quarters, BDRL averaged $-0.02 in diluted EPS.
Key Financial Metrics
Return on equity for Blonder Tongue Laboratories, Inc. stands at 42.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -8.6%, showing how much profit it generates from its asset base. A current ratio of 0.57 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Blonder Tongue Laboratories, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -4.42 places it in the distress zone, a signal of elevated financial risk.
BDRL Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2024
Bull Case vs Bear Case
Bull Case
- Insiders seem to be accumulating shares, which often signals confidence in the company's future prospects.
- The community is buzzing about potential new partnerships, suggesting growth opportunities ahead.
- There's a growing belief that the market is undervaluing BDRL's long-term potential in its niche.
- Positive sentiment is building around the company's strategic shift towards emerging technologies.
Bear Case
- Recent community chatter indicates concerns about increased competition eroding market share.
- Some investors are worried about potential delays in product launches impacting revenue projections.
- There's a perception that the company's communication strategy isn't effectively addressing market anxieties.
- Negative sentiment has surfaced regarding the company's ability to adapt quickly to changing market conditions.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2025 | $3M | -$314,000 | -$0.02 |
| Q4 2024 | $3M | -$483,000 | -$0.03 |
| Q3 2024 | $3M | -$427,000 | -$0.03 |
| Q2 2024 | $3M | -$98,000 | -$0.01 |
Based on FMP financials and quantitative analysis
BDRL Latest News
No recent news available for BDRL.
Leadership: Robert J. Palle Jr.
CEO
Robert J. Palle Jr. serves as the CEO of Blonder Tongue Laboratories, Inc. His leadership is critical in guiding the company's strategic direction and overseeing its operations. Information regarding his specific career history, education, and previous roles is not available in the provided data. However, as CEO, he is responsible for driving the company's growth and profitability.
Track Record: Due to the lack of available data, it is not possible to assess Robert J. Palle Jr.'s track record at Blonder Tongue Laboratories, Inc. Key achievements, strategic decisions, and company milestones under his leadership are currently unknown.
BDRL OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Blonder Tongue Laboratories, Inc. may not meet the minimum financial or reporting standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosures and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This tier often includes companies that are distressed, undergoing restructuring, or have chosen not to comply with higher reporting standards. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and regulatory scrutiny compared to listed companies.
- OTC Tier: OTC Other
- Limited financial disclosure may obscure the true financial health of the company.
- Lower trading volumes can lead to price volatility and difficulty in buying or selling shares.
- The company may not meet the listing requirements of major exchanges, indicating potential financial or operational challenges.
- OTC stocks are subject to less regulatory oversight, increasing the risk of fraud or manipulation.
- The OTC Other tier carries a higher risk of delisting or going out of business.
- Verify the company's financial statements and SEC filings (if any) to assess its financial health.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Review the company's OTC Markets profile for any disclosures or warnings.
- Check for any news articles or press releases that may impact the company's stock price.
- Consult with a financial advisor to assess the risks and potential rewards of investing in OTC stocks.
- Determine if the company is current in its reporting requirements.
- The company has been in business since 1950, indicating a long history in the industry.
- Blonder Tongue has a comprehensive product portfolio.
- The company has a CEO, Robert J. Palle Jr.
- The company has a physical headquarters in Old Bridge, New Jersey.
Common Questions About BDRL (Technology)
What happened to Blonder Tongue Laboratories, Inc. (BDRL) stock?
Blonder Tongue Laboratories, Inc. (BDRL) no longer trades on public markets. It was delisted in January 2026. The figures below are historical and are not a current quote.
Can I still buy BDRL shares?
No. BDRL stopped trading on public markets in January 2026, so the shares are not available through a broker. Anything you see quoted for BDRL elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before BDRL stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Blonder Tongue Laboratories, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Blonder Tongue Laboratories, Inc. do?
Blonder Tongue Laboratories, Inc. specializes in providing television signal encoding, transcoding, digital transport, and broadband product solutions. The company offers a range of products, including encoders/transcoders, coax distribution products, CPE products like Android-based IPTV set-top boxes, and digital modulation products.
What are the main risks for BDRL?
Blonder Tongue Laboratories, Inc. faces several risks, including rapid technological advancements that could render existing products obsolete. Intense competition from larger and more established companies poses a threat to its market share. Economic downturns could reduce demand for the company's products and services. Limited financial resources may hinder its ability to invest in research and development.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available for in-depth analysis.
- OTC market stocks carry higher risk and require thorough due diligence.